HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.

AbstractOBJECTIVES:
The purpose of this study was to compare long-term clinical outcomes after implantation of drug-eluting stents (DES) and bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI).
BACKGROUND:
The evidence of long-term efficacy and safety after implantation of DES in patients with complex lesions is scarce.
METHODS:
We randomly assigned 626 patients with STEMI referred within 12 h to have a DES or a BMS implanted in the infarct-related lesion with or without distal protection during primary percutaneous coronary intervention.
RESULTS:
At 3 years, target lesion revascularization was 6.1% in the DES group compared with 16.3% in the BMS group (p<0.001), and the rate of major adverse cardiac events was 11.5% versus 18.2%, respectively (p=0.02). Whereas all-cause mortality did not differ significantly, the rate of cardiac death was higher in the DES group, 6.1% versus 1.9% for the BMS group (p=0.01). The occurrence of reinfarction, stroke, and stent thrombosis was similar.
CONCLUSIONS:
Implantation of DES in patients with STEMI reduces the long-term rate of major adverse cardiac events compared with BMS, but patients with DES had a higher risk of cardiac death not attributed to myocardial infarction or stent thrombosis. (Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction [DEDICATION]; NCT00192868)
AuthorsAnne Kaltoft, Henning Kelbaek, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans E Bøtker, Kari Saunamäki, Lars R Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald H Christiansen, Jan Ravkilde, Lars Køber, Klaus F Kofoed, Christian J Terkelsen, Steffen Helqvist
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 56 Issue 8 Pg. 641-5 (Aug 17 2010) ISSN: 1558-3597 [Electronic] United States
PMID20688033 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Angioplasty, Balloon
  • Drug-Eluting Stents (adverse effects)
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Myocardial Infarction (mortality, physiopathology, therapy)
  • Stents (adverse effects)
  • Survival Rate
  • Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: